ABCAM PLC / ADR (OTCMKTS: ABCZY) was downgraded from a "buy" rating to a "sell" rating by Zacks Investment Research in a report published Tuesday, informs Zacks.com.
"Abcam PLC distributes the antibodies and associated protein research tools, according to Zacks. Primary and secondary antibodies, enzymes, peptides, lysates, biochemicals, immunoassays, and other kits are part of its line. Abcam PLC has its head....
Tags : OTCMKTS ABCZY, quest ,
comments (0)